GleamWall
中文EN

CORZ Core Scientific, Inc./tx

Finance Services · Nasdaq · SEC CIK 1839341 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY77.2%
TTM net income YoY86.1%
TTM EPS YoY-650.0%
Revenue 3-yr CAGR7.1%
Net income 3-yr CAGR—

Margins

Gross margin41.2%
Operating margin-73.6%
Net margin-18.6%
FCF margin-223.0%
EBITDA margin-62.8%

Returns

ROE—
ROA-2.7%
ROIC (approx.)-98.4%
Asset turnover0.15x

Leverage & solvency

Liabilities / assets118.4%
Debt / equity—
Current ratio0.67x
Interest coverage—

Cash quality & payout

Operating cash flow / net income-4.08x
Accruals ratio-13.8%
Payout ratio—
Capex / revenue298.9%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-09-302026Q22026-06-302026Q12026-03-312025Q4*2025-12-312025Q32025-09-302025Q22025-06-302025Q12025-03-312024Q4*2024-12-31
Income statement
Revenue$232.87M$164.20M$115.24M$79.76M$81.10M$78.63M$79.53M$94.92M
Cost of revenue$109.59M$94.16M$85.14M$59.01M$77.20M$73.60M$71.31M$90.16M
Gross profit$123.27M$70.04M$30.11M$20.75M$3.90M$5.03M$8.21M$4.76M
R&D expense———————$5.02M
SG&A expense$45.55M$49.39M$44.85M-$7.18M$47.40M$45.28M$32.29M$25.04M
Operating income$72.35M-$78.47M-$310.42M-$119.28M-$54.79M-$26.28M-$47.04M-$65.39M
Interest expense$54.07M$40.65M$8.16M—$4.76M$4.75M$4.75M—
Pretax income$1.07B-$1.15B-$346.59M$214.25M-$143.90M-$936.64M$576.46M-$290.77M
Income tax-$106.51M$1.91M$600,000$95,000$125,000$158,000$205,000$375,000
Net income$1.18B-$1.16B-$347.19M$214.15M-$144.03M-$936.80M$576.25M-$291.15M
EBITDA$90.25M-$63.17M-$293.77M-$105.19M-$38.69M-$7.68M-$27.31M-$39.35M
EPS (basic)3.42-3.32-1.06—-0.45-0.041.42-0.69
EPS (diluted)0.47-3.32-1.06—-0.45-0.041.24-0.69
Weighted avg. shares (diluted)469.01M325.33M322.91M—318.56M317.99M363.31M—
Balance sheet
Cash & equivalents$803.94M$1.77B$1.01B$311.38M$453.44M$581.35M$698.73M$836.98M
Receivables——————$1.02M$1.02M
Current assets$1.42B$2.44B$1.45B$895.54M$1.06B$1.00B$833.18M$903.96M
PP&E, net$2.63B$1.77B$1.34B$1.29B$954.12M$701.29M$522.98M$433.47M
Intangibles$737.53M$228.62M—$1.08M————
Total assets$5.94B$5.26B$3.07B$2.35B$2.17B$1.85B$1.50B$1.48B
Current liabilities$2.11B$2.74B$2.66B$781.40M$669.86M$562.72M$195.51M$134.56M
Short-term debt——$993.94M$0————
Long-term debt$4.30B$4.30B$1.06B$1.06B————
Total debt$4.30B$4.30B$2.06B$1.06B————
Total liabilities$7.03B$7.68B$4.38B$3.31B$3.42B$3.04B$1.81B$2.42B
Shareholders' equity-$1.09B-$2.42B-$1.31B-$962.74M-$1.25B-$1.19B-$308.82M-$943.05M
Net debt$3.50B$2.53B$1.05B$748.95M————
Shares outstanding321.97M319.59M316.95M314.23M308.38M303.15M299.09M292.61M
Cash flow statement
Operating cash flow$65.29M-$18.93M$249.88M$153.07M$131.78M$34.00M-$45.04M$13.80M
Capital expenditure$540.74M$565.02M$389.23M$274.81M$244.49M$121.28M$83.98M$28.76M
Free cash flow-$475.44M-$583.95M-$139.35M-$121.74M-$112.71M-$87.28M-$129.02M-$14.95M
Investing cash flow-$983.02M-$796.24M-$386.65M-$273.32M-$254.36M-$119.61M-$89.02M-$28.80M
Financing cash flow$7.88M$2.22B$971.38M-$21.81M-$5.32M-$31.77M-$4.20M$598.17M
Depreciation & amortization$17.90M$15.30M$16.65M$14.10M$16.10M$18.60M$19.73M$26.04M
Stock-based compensation$25.18M$18.24M$17.76M$27.93M$29.95M$24.17M$16.18M$23.97M

Free plan shows the latest 8 periods; Pro shows all 23 🔒

· Financial companies (banks, insurers, …) usually do not report gross profit or operating income; bank revenue is net revenue (net interest income + noninterest income), smaller than "gross interest income + noninterest income".

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.